Search Results - Salmir Nasic
- Showing 1 - 14 results of 14
-
1
Compliance to adjuvant endocrine therapy and survival in breast cancer patients. by Chaido Chamalidou, Salmir Nasic, Barbro Linderholm
Published 2023-01-01
Article -
2
-
3
Impact of obesity on outcome of severe bacterial infections. by Åsa Alsiö, Salmir Nasic, Lars Ljungström, Gunnar Jacobsson
Published 2021-01-01
Article -
4
-
5
-
6
Changes in functional outcome over five years after stroke by Åsa Rejnö, Salmir Nasic, Kerstin Bjälkefur, Eric Bertholds, Katarina Jood
Published 2019-06-01
Article -
7
Self-rated health over the first five years after stroke by Kerstin Bjälkefur, Salmir Nasic, Eric Bertholds, Katarina Jood, Åsa Rejnö
Published 2020-10-01
Article -
8
-
9
Prevalence of chronic pain in children and adolescents with psychiatric conditions by Sara Lundqvist, Rajna Knez, Karin Nagy, Salmir Nasic, Nóra Kerekes, Anne‐Katrin Kantzer
Published 2023-06-01
Article -
10
-
11
Diagnostic accuracy and clinical applicability of the Swedish version of the 4AT assessment test for delirium detection, in a mixed patient population and setting by Yvonne A. Johansson, Theofanis Tsevis, Salmir Nasic, Catharina Gillsjö, Linda Johansson, Nenad Bogdanovic, Elisabeth Kenne Sarenmalm
Published 2021-10-01
Article -
12
Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specim... by Slavica Janeva, Toshima Z. Parris, Salmir Nasic, Shahin De Lara, Karolina Larsson, Riccardo A. Audisio, Roger Olofsson Bagge, Anikó Kovács
Published 2021-04-01
Article -
13
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer by Slavica Janeva, Ellen Krabbe, Toshima Z. Parris, Salmir Nasic, Marie Sundquist, Per Karlsson, Riccardo A. Audisio, Roger Olofsson Bagge, Anikó Kovács
Published 2023-04-01
Article -
14
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. by Åsa Alsiö, Karolina Rembeck, Galia Askarieh, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Bart L Haagmans, Salmir Nasic, Johan Westin, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
Published 2012-01-01
Article